Liberia vs Panama: Antiretroviral therapy coverage for PMTCT
Liberia
88.0%
in 2024
Panama
86.0%
in 2024
Liberia rank
31st
Panama rank
34th
Antiretroviral therapy coverage for PMTCT over time
- Liberia
- Panama
How they compare
Liberia currently reports 88.0% against 86.0% in Panama, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Panama ahead.
Liberia ranks 31st and Panama ranks 34th of 84 countries.
Panama has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Liberia | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.3% | 41.4% | 39.1% | Panama |
| 2010s | 40.8% | 77.7% | 36.9% | Panama |
| 2020s | 72.8% | 85.0% | 12.2% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Liberia or Panama?
- Liberia, at 88.0% against 86.0% in Panama as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Liberia and Panama?
- 2.0%, with Liberia ahead.
- How many years of comparable data are there for Liberia and Panama?
- 25 years are reported by both, from 2000 to 2024.
- How do Liberia and Panama rank globally for antiretroviral therapy coverage for pmtct?
- Liberia ranks 31st and Panama ranks 34th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).